Compare Bank Central Asia Tbk (BBCA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Central Asia Tbk vs Merck Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,375 (market cap 774.97T, 83.21M 24h volume), while Merck Tbk. trades at Rp3,910 (market cap 1.79T, 28.4K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 432.9× Merck Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (83.21M versus 28.4K). Which is the better fit depends on your goals.
| BBCA | MERK | |
|---|---|---|
Market Cap | 774.97T | 1.79T |
Volume | 83.21M | 28.4K |
Lot | 832.08K | 284 |
Turnover | 526.91B | 111.11M |
Average Price | 6,332.47 | 3,912.29 |
Value | 526.91B | 111.11M |
Indicative Equilibrium Price | 6,375 | 3,910 |
Indicative Equilibrium Volume | 417.93K | 6 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Central Asia Tbk
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
